On November 3rd, Istanbul hosted the First IVT-MGI Conference, immersing us in the future of Omics.

Collaborating with our distributor, Invitrotek, MGI experts, and a vibrant community of researchers and professionals, the conference delved into MGI's DNBSEQ™ Technology. This provided invaluable insights into sequencing technology advancements, unveiling NGS platforms reshaping omics research.

The event offered a unique opportunity to connect with a diverse community of scientists and industry leaders. At the core was the realization that the future of genomics has arrived, poised to shape science and healthcare in unprecedented ways.

Discover more about MGI's innovative products and the groundbreaking technologies discussed at the conference: MGI Sequencers.

To relive highlights from the IVT-MGI 1st Conference, don't forget to check out more details on IVT-MGI and the attached video.

As we reflect on this enriching experience, we invite you to stay connected and keep pushing the boundaries of science with us. Exciting updates and opportunities await on this incredible journey! 

About Invitrotek

Invitrotek, IVT is a sales & marketing company which is focused on molecular diagnostics and genetic testing market in Turkey. Established in January 2009, IVT aims to be in the process of building a healthier community and future with the help of its stakeholders in the Turkish healthcare value chain.

The team of employees brings the company’s core competency into existence with their market expertise and field knowledge. In the light of the fact that having a high-quality after-sales service is among the important success factors in the Turkish IVD market, IVT has a well-experienced product support and technical service department and put a training program into place for its sub-dealers.

Another important asset for the company is its established distribution network consisting of direct sales force and well-respected regional dealers. With the help of its well-established distribution network, IVT has the ability to create high product penetration rates within a short term of marketing.

The company’s main product portfolio consists of NGS(Next Generation Sequencing) Systems from MGI, WES(Whole Exome Sequencing), CES(Clinical Exome Sequencing and Custom design NGS kits from Twist Bioscience, MLPA kits from MRC-Holland, NGS panels from NanodigmBio, line assays from Veinnalab, Drug Testing products from Siemens Healthineers, Immunochemistry products from Diasorin and controls for diagnostic testing form UTAK.

About MGI